|
Corticosteroid Clinical Trials
2 actively recruiting trials across 2 locations
▼ -2 trials since June 2026
Also known as: Systemic corticosteroid, dexamethasone, methylprednisolone
Pipeline
Phase 2: 1Phase 4: 1
Top Sponsors
- Merck Sharp & Dohme LLC1
- Aurinia Pharmaceuticals Inc.1
Indications
- Lupus Nephritis1
- Lupus1
- Carcinoma, Non-Small-Cell Lung1
- Lung Cancer1
- Cancer1
La Mesa, California1 trial
PRESERVE: LUPKYNIS in Combination With Belimumab, Obinutuzumab or Anifrolumab in Patients With Lupus Nephritis
Purushotham & Akther Kotha MD, Inc.
Phase 4
Lexington, Kentucky1 trial
A Study of Investigational Agents in Participants With Previously Treated Stage IV Nonsquamous Non-small Cell Lung Cancer (NSCLC) (MK-3475-01H/KEYMAKER-U01)
University of Kentucky Chandler Medical Center ( Site 0019)
Phase 2
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.